tiprankstipranks
Bluebird Bio reports Q4 revenue $7.8M, consensus $16.68M	.
PremiumThe FlyBluebird Bio reports Q4 revenue $7.8M, consensus $16.68M .
23d ago
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
PremiumThe Fly
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
1M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
1M ago
Bluebird Bio price target lowered by $3 at Wells Fargo, here’s why
PremiumThe FlyBluebird Bio price target lowered by $3 at Wells Fargo, here’s why
4M ago
Bluebird in deal with group representing 100M covered lives, after FDA approval
PremiumThe Fly
Bluebird in deal with group representing 100M covered lives, after FDA approval
4M ago
Bluebird Bio pricing and label concerns are overdone, says Baird
PremiumThe Fly
Bluebird Bio pricing and label concerns are overdone, says Baird
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100